Unigestion Holding’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Unigestion Holding's PFE Position: Q4 2023 in Review
Unigestion Holding sold out of Pfizer (PFE) in Q4 2023, closing a stake of 91,867 shares — an estimated $2.95M sold.
Unigestion Holding first reported a position in PFE in Q2 2018 and held it in 21 quarters. The position peaked at $57.9M in Q3 2018. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Unigestion Holding reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- Unigestion Holding sold 91,867 Pfizer shares in Q4 2023, an estimated $2.95M.
- Unigestion Holding first reported a position in Pfizer in Q2 2018 and held it in 21 quarters.
- Unigestion Holding's Pfizer position peaked at $57.9M in Q3 2018.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Unigestion Holding's 13F filing for Q4 2023, filed 14 Feb 2024.